Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Replication”

101 trials

Showing 20 of 101 results

Large-scale testing (Phase 3)Study completedNCT04685512
What this trial is testing

Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home

Who this might be right for
Covid19
University Hospital, Caen 60
Not applicableUnknownNCT02162797
What this trial is testing

Zinc Supplementation Effect on Immune Recovery in HIV Patients

Who this might be right for
HIVAIDSImmunological Deficiency+2 more
CES University 40
Early research (Phase 1)Study completedNCT00005779
What this trial is testing

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Testing effectiveness (Phase 2)Study completedNCT00065104
What this trial is testing

Dehydroepiandrosterone Effects on HIV-1 Replication

Who this might be right for
HIV Infections
National Center for Complementary and Integrative Health (NCCIH) 40
Post-approval studies (Phase 4)UnknownNCT00840762
What this trial is testing

A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication

Who this might be right for
HIV-1HIV Infections
Ruth M. Rothstein CORE Center 756
Early research (Phase 1)Study completedNCT00026624
What this trial is testing

Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00055094
What this trial is testing

Treatment of Acute HIV Infection to Preserve Immune Function

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Large-scale testing (Phase 3)Study completedNCT00935480
What this trial is testing

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Who this might be right for
HIV Infections
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 17
Not applicableWithdrawnNCT00006415
What this trial is testing

Patients Who Recently Have Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT01453933
What this trial is testing

RAltegravir Switch STudy: Effects on Endothelial Recovery

Who this might be right for
HIV InfectionEndothelial Dysfunction
UMC Utrecht 24
Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Early research (Phase 1)Study completedNCT01915212
What this trial is testing

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 69
Not applicableUnknownNCT01473849
What this trial is testing

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionHepatitis C
Sociedad Española de Trasplante Hepático 179
Not applicableEnded earlyNCT00001651
What this trial is testing

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

Who this might be right for
HIVHealthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT01492985
What this trial is testing

Lipopeptide Immunisation With GTU-multiHIV Trial

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 103
Early research (Phase 1)Study completedNCT00000729
What this trial is testing

Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00520897
What this trial is testing

Integrase Inhibitor (MK-0518) Viral Decay

Who this might be right for
HIV Infections
Canadian Immunodeficiency Research Collaborative 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation